Britt Drogemoller
Britt Drogemoller
Assistant Professor, Department of Biochemistry & Medical Genetics, University of Manitoba
No verified email - Homepage
Cited by
Cited by
Exome sequencing and the management of neurometabolic disorders
M Tarailo-Graovac, C Shyr, CJ Ross, GA Horvath, R Salvarinova, XC Ye, ...
New England Journal of Medicine 374 (23), 2246-2255, 2016
Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation
L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2011
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ...
The American Journal of Human Genetics 104 (6), 1116-1126, 2019
Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population
GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich
Annals of human genetics 74 (4), 340-350, 2010
Characterization of the genetic profile of CYP2C19 in two South African populations
BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ...
Pharmacogenomics 11 (8), 1095-1103, 2010
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ...
BMC medical genetics 14 (1), 1-15, 2013
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer
BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ...
JAMA oncology 3 (11), 1558-1562, 2017
Characterization of the genetic variation present in CYP3A4 in three South African populations
BI Drogemoller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ...
Frontiers in Genetics 4, 17, 0
Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment
BI Drögemöller, GEB Wright, DJH Niehaus, R Emsley, L Warnich
Pharmacogenetics and genomics 23 (12), 666-674, 2013
Germline de novo mutations in ATP1A1 cause renal hypomagnesemia, refractory seizures, and intellectual disability
KP Schlingmann, S Bandulik, C Mammen, M Tarailo-Graovac, R Holm, ...
The American Journal of Human Genetics 103 (5), 808-816, 2018
Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS
ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ...
New England Journal of Medicine 380 (15), 1433-1441, 2019
Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ...
Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019
Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients
BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ...
Clinical Cancer Research 24 (8), 1866-1871, 2018
De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome
S Langlois, M Tarailo-Graovac, B Sayson, B Drögemöller, A Swenerton, ...
European Journal of Human Genetics 24 (6), 949-953, 2016
PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights
DL Johnstone, HH Al-Shekaili, M Tarailo-Graovac, NI Wolf, AS Ivy, ...
Brain 142 (3), 542-559, 2019
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
K Kowalec, GEB Wright, BI Drögemöller, F Aminkeng, AP Bhavsar, ...
Nature genetics 50 (8), 1081-1085, 2018
Atypical cerebral palsy: genomics analysis enables precision medicine
AM Matthews, I Blydt-Hansen, B Al-Jabri, J Andersen, M Tarailo-Graovac, ...
Genetics in Medicine 21 (7), 1621-1628, 2019
Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications
BI Drögemöller, GEB Wright, DJH Niehaus, RA Emsley, L Warnich
Pharmacogenomics 12 (12), 1717-1728, 2011
Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis
KM Gibson, KA Morishita, P Dancey, P Moorehead, B Drögemöller, X Han, ...
Arthritis & Rheumatology 71 (10), 1747-1755, 2019
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
BI Drögemöller, GEB Wright, J Shih, JG Monzon, KA Gelmon, CJD Ross, ...
Breast cancer research and treatment 173 (3), 521-532, 2019
The system can't perform the operation now. Try again later.
Articles 1–20